Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF

Detalles Bibliográficos
Autores principales: Lehmacher, W., Klasser, M., Duering, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805708/
https://www.ncbi.nlm.nih.gov/pubmed/26860847
http://dx.doi.org/10.1007/s00520-016-3116-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805708/
https://www.ncbi.nlm.nih.gov/pubmed/26860847
http://dx.doi.org/10.1007/s00520-016-3116-3

Ejemplares similares